X4 PHARMACEUTICALS INC (XFOR) Stock Income Statement
NASDAQ:XFOR - Nasdaq - US98420X1037 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.56M | 0.00 | 0.00 | 0.00 | 3.00M | |||
| Cost Of Goods | 797.00K | N/A | N/A | N/A | N/A | |||
| Gross Profit | 1.76M | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 143.16M | 107.52M | 88.08M | 75.35M | 62.88M | |||
| Research and Development | 81.64M | 72.02M | 61.06M | 50.65M | 41.93M | |||
| Selling, General, and Administrative Expenses | 61.52M | 35.51M | 27.02M | 24.70M | 20.94M | |||
| Operating Income | -141.40M | -107.52M | -88.08M | -75.35M | -59.88M | |||
| Interest Income/Expense | -3.00M | 5.88M | -2.07M | -4.00M | -2.85M | |||
| Other Income/Expense | 2.26M | 554.00K | -4.20M | 430.00K | 910.00K | |||
| Non Recurring Items | 105.00M | 0.00 | 510.00K | -9.76M | -160.00K | |||
| Income Before Taxes | -37.14M | -101.09M | -93.84M | -88.68M | -61.98M | |||
| Income Tax | 310.00K | 78.00K | 30.00K | 20.00K | 150.00K | |||
| Net Income | -37.45M | -101.17M | -96.41M | -102.64M | -62.13M | |||
| EBITDA | -140.60M | -107.10M | -87.57M | -74.85M | -59.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.19 | -0.57 | -1.52 | -3.99 | -3.09 | |||
| Non GAAP EPS | -0.71 | -0.60 | -1.87 | -3.70 | -2.97 | |||
| Statistics | ||||||||
| Gross Profit Margin | 68.83% | N/A | N/A | N/A | N/A | |||
| Profit Margin | -1464.61% | N/A | N/A | N/A | -2071.00% | |||
| Operating Profit Margin | -5529.96% | N/A | N/A | N/A | -1996.00% | |||
All data in USD